Dopavision Closes €12 Million Series A Round to Advance Digital Childhood Myopia Therapeutic Through Clinical Trials
Dopavision, a company pioneering the development of digital therapeutics, today announced the closing of a €12 million S…
Dopavision, a company pioneering the development of digital therapeutics, today announced the closing of a €12 million S…
Immer mehr Kinder sind kurzsichtig. Ein Grund: sie befinden sich viel in Innenräumen, schauen zu viel im Nahbereich und…
Canvys - Visual Technology Solutions expands its product portfolio with a new 10.1" display with HD resolution (1280 x 8…
. Transparency Market Research (TMR) has published a new report on the corneal topographers market for the forecast peri…
BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, FUJIFILM C…
Arvato Systems migrates software for implementation of the EU’s Falsified Medicines Directive (FMD) in less than eight w…
Bis 2050 werden fast 50% der Weltbevölkerung von Myopie oder Kurzsichtigkeit betroffen sein. Das belegt eine Vorhersage…
According to the report, the global corneal topographers market was valued at ~US$ 920 Mn in 2018, and is projected to e…
Canvys, A Division of Richardson Electronics, Ltd. (NASDAQ: RELL), is expanding its product portfolio with a new 15.6" F…
VSY Biotechnology GmbH, an innovation-driven company with its progressive R&D activities in ophthalmology, visco supplem…